DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: OCREVUS (ocrelizumab)
       *****************************************************
       #Post#: 2077--------------------------------------------------
       (McGill University) Developing the first effective drug for PPMS
   DIR By: agate
       Date: May 11, 2018, 1:24 pm
       ---------------------------------------------------------
       An informative news story about Ocrevus from McGill University
       in Canada (May 11, 2018), "Developing the first effective drug
       for progressive MS":
  HTML http://publications.mcgill.ca/medenews/2018/05/10/developing-the-first-effective-drug-for-progressive-ms/
       This part is something I haven't seen mentioned much elsewhere:
       --- Quote ---
       >
       > It should be noted that clinical data came from patients
       between the ages of 18 and 55.
       > “It’s not clear how well ocrelizumab works in older people who
       have had progressive multiple sclerosis for a long time,”
       cautions Dr. Arnold [a neurologist who worked in the development
       of ocrelizumab], adding that research continues.
       > The Multiple Sclerosis Society of Canada notes that “the
       safety and efficacy of ocrelizumab outside of the age range of
       18 to 55 is unknown.” The Society advises older patients who are
       interested in ocrelizumab to consult their neurologist.
       >
       --- End Quote ---
       *****************************************************
       Page 1 of 1